Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0989747
Funder
Australian Research Council
Funding Amount
$400,000.00
Summary
Ultrafast Dynamics Measurement Facility for the Physical, Biochemical, and Materials Sciences. The term "ultrafast revolution" describes the transformations in science due to ultrafast laser technology. Today, ultrafast lasers are used in surgery, nanomaterial fabrication, biomedical imaging, spectroscopic investigations, and new applications are still emerging. This facility will draw together leading chemists, physicists, and engineers to investigate key ultrafast processes and phenomena in th ....Ultrafast Dynamics Measurement Facility for the Physical, Biochemical, and Materials Sciences. The term "ultrafast revolution" describes the transformations in science due to ultrafast laser technology. Today, ultrafast lasers are used in surgery, nanomaterial fabrication, biomedical imaging, spectroscopic investigations, and new applications are still emerging. This facility will draw together leading chemists, physicists, and engineers to investigate key ultrafast processes and phenomena in the physical, biochemical and material sciences. This is of strategic importance to keep Australia at the global forefront for scientific endeavours, supporting new research and commercial opportunities. This facility will also produce highly trained graduates, who will find employment in industry throughout Australia and globally.Read moreRead less
Computer simulation of DNA biochips. The DNA biochip technology has been a major breakthrough in cell biology and clinical analysis. Companies in Australia and in the rest of the world are now developing biochips for genome sequencing and point-of-care diagnosis. DNA biochips have the potential to provide simple, fast and accurate clinical analysis, thus enhancing the efficiency of medical treatments and reducing the costs of health care.
The structural properties of the immobilized DNA are cri ....Computer simulation of DNA biochips. The DNA biochip technology has been a major breakthrough in cell biology and clinical analysis. Companies in Australia and in the rest of the world are now developing biochips for genome sequencing and point-of-care diagnosis. DNA biochips have the potential to provide simple, fast and accurate clinical analysis, thus enhancing the efficiency of medical treatments and reducing the costs of health care.
The structural properties of the immobilized DNA are critical for determining the DNA chip sensitivity and efficiency. A fundamental understanding of the molecular interactions at the surface of a biochip is therefore not only relevant for the scientific community, but can have direct implications for the design of improved DNA chips.Read moreRead less